2021

1. 3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition

   Journal of medicinal chemistry, Vol. 64, Núm. 1, pp. 458-480